Debiopharm and ThinkingNodeLife.ai Partner on AI-Driven Cancer Drug Development
Debiopharm and ThinkingNodeLife.ai (TNL), a pioneer in AI-powered drug discovery, parteners to propel AI cancer drug development.
Source: hitconsultant.net
Stay updated with breaking news from Action Validation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Debiopharm and ThinkingNodeLife.ai (TNL), a pioneer in AI-powered drug discovery, parteners to propel AI cancer drug development.
Debiopharm, an independent biopharmaceutical company headquartered in Switzerland, and ThinkingNodeLife.ai (TNL), a trailblazer in AI Digital Cells Lab in USA, are pleased to announce a collaborative partnership aimed at advancing the development of...